Trial intelligence / Profile preview

Interaction of Celecoxib or Ibuprofen with Aspirin in OA Patients with IHD

NCT00565500Phase 4Completed

Sponsor
Università degli Studi Gabriele d'Annunzio Chieti e Pescara
Start
Apr 2003
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of celecoxib in osteoarthritis (OA) (3 arms), sponsored by Università degli Studi Gabriele d'Annunzio Chieti e Pescara. Primary endpoint: Serum Thromboxane B2 at 1 week. Started Apr 2003; status: completed.

02

Drugs

celecoxib
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00565500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00565500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call